Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation
Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2018.03071
Full Text
Open PDFAbstract
Available in full text
Date
January 22, 2019
Authors
Publisher
Frontiers Media SA